A scrambled peptide rearranges a sequence while keeping its amino-acid composition. Researchers may use it to ask whether an observed effect depends on the original order. The word “scrambled” describes how the material was designed; it does not guarantee that the new sequence has no effect.
A four-residue example
Consider the invented sequence R-K-L-W and a proposed control W-L-R-K. Both contain one arginine, one lysine, one leucine and one tryptophan. They have the same four ingredients, but in a different order. JPT describes scrambled libraries using this composition-preserving approach. [1]
The mass can match even when the order does not
If both chains also have identical end groups and other modifications, rearranging those same residues preserves elemental composition and expected intact mass. A matching mass alone would not tell these two sequences apart. That is why your order needs the complete control sequence, not just “same mass, scrambled.”
Do not assume the control is inactive
A rearranged chain can still interact with your assay. It can also differ in practical handling. Treat it as a candidate control and test its suitability. Depending on the research question, you may need a vehicle-only condition, an unrelated sequence or more than one scrambled sequence. A sequence design is not a substitute for those checks.
Keep the comparison understandable
If the aim is to study sequence order, avoid quietly changing the label, terminal groups, salt form or requested purity at the same time. Record any differences that cannot be avoided. Otherwise, a difference in the experiment may have several possible explanations.
Send both sequences in one clear table
Give each sequence an identifier. Include residue order, D/L configuration where relevant, terminal groups, modifications, quantity and required checks. Ask the supplier to confirm the composition comparison and the available identity evidence before synthesis. You can send this pair through NHD’s quotation form for project assessment.
Useful links
For laboratory research, development and manufacturing only. Not for human or veterinary use.
Sources and examples
Reference records explain the topic; they do not establish NHD stock, a supplied lot’s results or clinical suitability. Examples explicitly labeled as hypothetical are calculations, not test data.
Sources & editorial method
AI-assisted drafting, source checks, translation and generated comic illustration. This is not independent peer review or supplied-lot verification.
1 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
Reference data and teaching examples are separated from NHD lot results; product specifications and availability require confirmation.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
Primary records and authoritative sources
- JPT: peptide library designs and technicalitiesJPT: peptide library designs and technicalities. Accessed 2026-10-03.
